Could cause temporary or reversible harm; serious harm is unlikely.
Failed Impurities/Degradation Specifications: Product is being recalled due to API related substances and unknown impurities that are above the specification limits.
| Distributed by / for | Teva Pharmaceuticals USA, Inc., North Wales, PA 19454 |
| NDC | 0555-0997-02 |
| Full product label | Fludrocortisone Acetate Tablets, USP 0.1mg, Rx Only, 100 Tablets per bottle, Manufactured in Canada By: Patheon, Inc., Mississauga, ON, Canada L5N 7K9, Manufactured For: Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 0555-0997-02. |
| Recalling firm | Teva Pharmaceuticals USA, Inc |
| Distribution | Nationwide in the USA and Puerto Rico |
| Quantity | 116,144 bottles |
| Recall initiated | 2024-06-28 |
| Report date | 2024-07-24 |
| Recall completed | — |
| Recall number | D-0601-2024 |
| Classification | Class II |
| FDA status | Ongoing |
| Origin on file | Parsippany NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗